202 related articles for article (PubMed ID: 9460289)
1. [Non-enzymatic glycosylation of lipoproteins in the pathogenesis of atherosclerosis in diabetics].
Calvo C
Rev Med Chil; 1997 Apr; 125(4):460-5. PubMed ID: 9460289
[TBL] [Abstract][Full Text] [Related]
2. Increased glycation of plasma lipoproteins in diabetic cynomolgus monkeys.
Wagner JD; Bagdade JD; Litwak KN; Zhang L; Bell-Farrow AD; Wang ZQ; Cefalu WT
Lab Anim Sci; 1996 Feb; 46(1):31-5. PubMed ID: 8699816
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein glyco-oxidation.
Picard S
Diabete Metab; 1995 Apr; 21(2):89-94. PubMed ID: 7621977
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein glycation and its metabolic consequences.
Lyons TJ
Diabetes; 1992 Oct; 41 Suppl 2():67-73. PubMed ID: 1526339
[TBL] [Abstract][Full Text] [Related]
5. [Glycosylated lipoproteins as atherogenic factor in diabetes (review of the literature)].
Denisenko TV
Vopr Med Khim; 1990; 36(2):5-10. PubMed ID: 2194367
[TBL] [Abstract][Full Text] [Related]
6. Carnosine and its constituents inhibit glycation of low-density lipoproteins that promotes foam cell formation in vitro.
Rashid I; van Reyk DM; Davies MJ
FEBS Lett; 2007 Mar; 581(5):1067-70. PubMed ID: 17316626
[TBL] [Abstract][Full Text] [Related]
7. Importance of glycation in the acceleration of low density lipoprotein (LDL) uptake into macrophages in patients with diabetes mellitus.
Makita T; Tanaka A; Nakano T; Nakajima K; Numano F
Int Angiol; 1999 Jun; 18(2):149-53. PubMed ID: 10424372
[TBL] [Abstract][Full Text] [Related]
8. [Diabetes mellitus as a risk factor for arteriosclerosis].
Maeda E; Yoshino G; Kasuga M
Nihon Rinsho; 1993 Aug; 51(8):2170-6. PubMed ID: 8411688
[TBL] [Abstract][Full Text] [Related]
9. [Metabolic consequences of the nonenzymatic glucosylation of apolipoproteins].
Ponsin G; Calvo C; Berthezene F
Diabete Metab; 1991; 17(6):497-502. PubMed ID: 1809594
[TBL] [Abstract][Full Text] [Related]
10. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
Chapman MJ; Guérin M; Bruckert E
Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of LDL and its subfractions to glycation.
Soran H; Durrington PN
Curr Opin Lipidol; 2011 Aug; 22(4):254-61. PubMed ID: 21734572
[TBL] [Abstract][Full Text] [Related]
12. [Lipoprotein glycation and glycoxidation: their importance in diabetes mellitus].
Actis Dato SM; Rebolledo OR
Medicina (B Aires); 2000; 60(5 Pt 1):645-56. PubMed ID: 11188909
[TBL] [Abstract][Full Text] [Related]
13. Glycation as an atherogenic modification of LDL.
Younis N; Sharma R; Soran H; Charlton-Menys V; Elseweidy M; Durrington PN
Curr Opin Lipidol; 2008 Aug; 19(4):378-84. PubMed ID: 18607185
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis.
Hodgkinson CP; Laxton RC; Patel K; Ye S
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2275-81. PubMed ID: 18818414
[TBL] [Abstract][Full Text] [Related]
15. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
[TBL] [Abstract][Full Text] [Related]
16. Glycation and oxidation: a role in the pathogenesis of atherosclerosis.
Lyons TJ
Am J Cardiol; 1993 Feb; 71(6):26B-31B. PubMed ID: 8434558
[TBL] [Abstract][Full Text] [Related]
17. Nonenzymatic glycosylation of proteins. II. Does glycosylation of low density lipoproteins affect lipid composition of erythrocyte membranes?
Watała C; Kordacka M
Ann Clin Res; 1987; 19(3):194-7. PubMed ID: 3674735
[TBL] [Abstract][Full Text] [Related]
18. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
[TBL] [Abstract][Full Text] [Related]
19. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
Rosenblat M; Karry R; Aviram M
Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
